Cargando…
Remdesivir use in severe and critical COVID-19 patients might be associated with lower incidence of arterial thrombotic events
INTRODUCTION: Venous thromboembolism (VTE) and arterial thrombotic (AT) events are a striking feature of severe COVID-19, however, relationship of remdesivir use and the risk of thrombotic events is unknown and has not been investigated before. METHODS: We retrospectively analyzed a cohort of 876 co...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170894/ https://www.ncbi.nlm.nih.gov/pubmed/37201450 http://dx.doi.org/10.1016/j.ajem.2023.05.007 |